Archive for April 2010

Doctors found guilty of getting rich vaccinating our children

Christina England Vactruth.com 04/30/2010 A staggering 1,992 Indian doctors were found guilty this week of yet again profiting from the pharmaceutical industries. The Medical Council of India have found that doctors have been violating professional ethics, by excepting gifts, hospitality and financial gains. In the article Nearly 2000 doctors named for taking pharma firms’ gifts-Politics … the Economic Times stated:- “Nearly 2,000 doctors have violated professional ethics by receiving gifts, hospitality or  monetary grants from pharmaceutical companies in the last three years according to the [...]



Grassley Probe: Pharma Provides 81% of NAMI Income

Vera Hassner Sharav AHRP 04/29/2010 The $$$ amounts–one might call them, “fees for services rendered”–reveal the truth about who wields the greatest influence on NAMI policies–and whose interests are being served by NAMI. For years NAMI (the National Alliance of Mental Illness) refused to dislcose it sources of income. But thanks to Senator Charles Grassley’s probe, the dollar amounts–”fees for services rendered,” one might call them–reveal the truth about who wields the greatest influence on NAMI policies–and whose interests are being served by NAMI. In [...]



Ministry admits proper guidelines not followed in vaccine trial

New Delhi: The Union Health ZeeNews.com 04/29/2010 Ministry has admitted that proper guidelines were not adhered to while carrying out trials of HPV vaccine among young girls in Andhra Pradesh. The admission was made by the Secretary Department of Health Research V M Katoch to the Parliamentary Standing Committee on health, headed by Amar Singh. When the committee drew the attention of the secretary to the DCGI (Drug Controller General of India) guidelines where under third phase trials of any drug or vaccine cannot be [...]



Glaxo’s Sales, Profit Increase

Jeanne Whalen Wall Street Journal 04/49/2010 Sales of the H1N1 swine-flu vaccine continued to buoy GlaxoSmithKline PLC’s earnings in the first quarter, helping to boost net profit by 19%, though Chief Executive Andrew Witty said a milder-than-expected pandemic has prompted some countries to try to reduce orders. He said Glaxo is trying to be as flexible as possible. It has allowed some countries, including Germany and the U.K., to cut their vaccine orders and pay less. In other cases, it is sending countries H5N1 vaccine, [...]



Sanofi-Aventis 1st quarter profit up 8.6 percent

Emma Vandore Associated Press 04/29/2010 PARIS — Sanofi-Aventis reported Thursday an 8.6 percent increase in first quarter net profit thanks to its swine flu vaccine and strong sales of diabetes treatment Lantus. France’s largest drug maker said net profit in the three-month period rose to euro1.71 billion ($2.26 billion) from euro1.58 billion a year earlier. Revenue rose 3.9 percent to euro7.39 billion. Sanofi-Aventis’ biggest selling product Lantus showed a 5.8 percent increase in sales to euro790 million, offsetting the impact of generic competition on its [...]